Sign up to save your podcasts
Or
Share #12 Justin Loke: Cytogenetics and TP53 in BMT for AML
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#12 Justin Loke: Cytogenetics and TP53 in BMT for AML
The presence of TP53 mutations is associated with an unfavorable outcome in patients allografted for acute myeloid leukemia (AML), leading some to question the benefit of an allogeneic stem cell transplantation (allo-SCT) for this patient group, although this has not been studied in a large cohort. Article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34268 ALSO AS AUDIO ON
https://podcasts.apple.com/us/podcast/trainee-pearls/id1596786132
https://open.spotify.com/show/2M1PWPZGW9Bz7PL5eh103Y
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/CarmeloGurnari
View all episodes
By The EBMT Trainee CommitteeThe presence of TP53 mutations is associated with an unfavorable outcome in patients allografted for acute myeloid leukemia (AML), leading some to question the benefit of an allogeneic stem cell transplantation (allo-SCT) for this patient group, although this has not been studied in a large cohort. Article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34268 ALSO AS AUDIO ON
https://podcasts.apple.com/us/podcast/trainee-pearls/id1596786132
https://open.spotify.com/show/2M1PWPZGW9Bz7PL5eh103Y
CONNECT WITH US
https://twitter.com/TheEBMT_Trainee
https://www.ebmt.org/trainee-committee
https://twitter.com/CarmeloGurnari